SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

CLDX RSS Feed
Add CLDX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/17/2017 12:28:14 AM - Followers: 98 - Board type: Free - Posts Today: 0

 

 

 Celldex Therapeutics, Inc. (CLDX)

 

slider-images-2

 slider-images-3
http://www.celldextherapeutics.com
 

 

 
Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
 
CIK
0000744218
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
 
Management: 
http://www.celldextherapeutics.com/about/management.php
 
 
Product Pipeline: 
http://www.celldextherapeutics.com/pipeline/pipeline-overview.php
 
 
News and Press Releases: 
http://ir.celldextherapeutics.com/releases.cfm
 
http://finance.yahoo.com/q/h?s=CLDX+Headlines

 

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 
 
Events and Presentations:
http://ir.celldextherapeutics.com/events.cfm
 
 
SEC Filings:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000744218&owner=exclude&count=40
 
 
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
 
 
Share Structure:
See SEC filings
 
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications
ir@celldextherapeutics.com


----------------------------------------------

November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
 

yes November 8, 2016  yes

 



http://www.fool.com/investing/2016/11/07/premium-celldex-therapeutics-inc-q3-results.aspx?source=djc&utm_campaign=article&utm_medium=feed&utm_source=djc


From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 

yesyesyesyesyesyesyesyesyesyesyesyesyesyes



--------------------------------------------
 

 
 

 

  


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

 

SureTrader
Interactive Brokers Advertisement
CLDX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX News: Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma 11/17/2017 08:01:00 AM
CLDX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 11/09/2017 04:31:15 PM
CLDX News: Current Report Filing (8-k) 11/09/2017 04:28:09 PM
CLDX News: Quarterly Report (10-q) 11/07/2017 08:23:59 AM
CLDX News: Current Report Filing (8-k) 11/07/2017 08:02:52 AM
PostSubject
#1489   Nice trend recently although on somewhat light volume trebeg 11/17/17 12:28:14 AM
#1488   Well gl to ya harry crumb 11/13/17 10:34:32 PM
#1487   Ok. Been down for a looooong time 2014shelby 11/09/17 10:24:02 PM
#1486   You may very well be right Harry but letsgogolfing 11/09/17 08:23:55 PM
#1485   been adding an accumulating, not selling/flipping anything. like harry crumb 11/07/17 10:04:21 PM
#1484   Yup same here. Well played. erehdogmai 11/07/17 01:19:05 PM
#1483   Couldn't resist had to take some profits on trebeg 11/07/17 01:16:01 PM
#1482   Nice little pop. Enjoy! erehdogmai 11/07/17 10:35:55 AM
#1481   Yeah, we may bounce around a bit but trebeg 11/02/17 10:55:02 PM
#1480   Got me a little concerned today but it erehdogmai 11/02/17 11:47:12 AM
#1479   Beer money good! LOL Not so sure this trebeg 11/01/17 08:02:30 AM
#1478   Bought Friday, already sold. It had a nice erehdogmai 10/31/17 11:16:07 PM
#1477   Bet you thought the PPS was going up trebeg 10/31/17 10:25:52 PM
#1476   Back in @2.36 on Friday. CLDX is so predictable. erehdogmai 10/31/17 09:57:40 AM
#1475   will need some new technology to get going again biotech2 10/26/17 11:27:41 AM
#1474   nice. $$$ harry crumb 10/25/17 07:20:58 PM
#1473   Yeah I played it a few years ago erehdogmai 10/25/17 10:55:29 AM
#1472   yes agree but its an oppertunity to add harry crumb 10/25/17 10:38:32 AM
#1471   Waaaay oversold. Looks like dumping or stoplosses.. erehdogmai 10/25/17 09:44:16 AM
#1470   agree, i see it gaining momo in december. $$$$ harry crumb 10/25/17 07:21:08 AM
#1469   CLDX move will take place in 2018 if fwb 10/24/17 10:30:16 AM
#1468   Good question. Will CLDX ever get back above 2014shelby 10/23/17 08:11:44 PM
#1467   How much patience Harry? I have about Keithz 10/23/17 08:01:44 PM
#1466   put another 30k in this today. should be harry crumb 10/23/17 05:32:47 PM
#1465   Like catching a falling knife here. I'm a erehdogmai 10/20/17 10:34:01 AM
#1464   I bought back in early this week for noretreat 10/04/17 04:30:18 PM
#1463   And? Is CLDX gonna come out with some 2014shelby 10/04/17 10:22:24 AM
#1462   Agree. In addition on the biggest up days trebeg 10/04/17 10:21:54 AM
#1461   insiders! harry crumb 10/04/17 09:15:04 AM
#1460   well yeah its better than 3! harry crumb 10/02/17 02:23:20 PM
#1459   Harry...I'd take that and be very happy. CLDX$$$$ trebeg 09/26/17 11:27:03 PM
#1458   A lot of buying leading up to the trebeg 09/26/17 11:24:03 PM
#1457   100% agree! i do believe this crawls to harry crumb 09/26/17 07:55:08 PM
#1456   What happen last week was Insurance Buying. Today fwb 09/26/17 03:03:03 PM
#1455   Relax Shelby. Won't happen until FDA approval which trebeg 09/26/17 12:33:24 PM
#1454   patience my friend, institutional ownership is nearing 60%, harry crumb 09/26/17 06:50:22 AM
#1453   PPS still $3. PPS been down for a 2014shelby 09/25/17 08:45:59 PM
#1452   interest is coming back for a reason, approval!! $$$ harry crumb 09/25/17 03:48:57 PM
#1451   where were you? taylorfleming 09/25/17 02:53:01 PM
#1450   That was a nice little ride. Hopefully we erehdogmai 09/25/17 12:08:37 PM
#1449   Have plenty Harry but will add more if trebeg 09/25/17 11:46:43 AM
#1448   agree, but adding shares now will make u harry crumb 09/25/17 08:16:41 AM
#1447   This stock is event driven and it will trebeg 09/25/17 12:04:37 AM
#1446   You are correct, I just think one day redskins020 09/24/17 12:13:51 AM
#1445   CLDX PPS still below $3. Just seems to 2014shelby 09/23/17 01:16:20 PM
#1444   wow a huge buy held back! institutional purchase, harry crumb 09/13/17 07:52:49 PM
#1443   How about now? 2014shelby 09/12/17 05:46:21 PM
#1442   huge upside may happen on positive catalysts, more harry crumb 09/12/17 10:10:21 AM
#1441   Good. $5+ coming? 2014shelby 09/11/17 09:52:05 PM
#1440   cldx needs to be outgoing with some news harry crumb 09/09/17 03:27:57 PM
PostSubject